DAVIE, Florida, Aug. 27, 2019 /PRNewswire/ -- LeafyWell (www.LeafyWell.com), a subsidiary of NxGen Brands, Inc  (NXGB), today announces having public figure, John Orlandini aka "JohnnyO" as a designated brand ambassador for LeafyWell and "NXGB". JohnnyO 

CARLSBAD, Calif., Aug. 27, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, announced today that GSK exercised its option to license Ionis' antisense medicines for people with chronic hepatitis B virus (CHB) infection following positive Phase 2 results.

ROCKVILLE, Md., Aug. 27, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that an interim trial update from the RGX-314 Phase I/IIa clinical trial for the treatment

HOUSTON, Aug. 27, 2019 /PRNewswire/ -- Legal-Bay, the premier Pre Settlement Funding Company, announced today that they are expanding their surgical funding department. Surgery funding is a fast and easy way for plaintiffs to get financing to pay for a medically-necessary surgical procedure when no insurance exists. Unfortunately, just because you've been injured—t

AURORA, Colo., Aug. 27, 2019 /PRNewswire/ -- Machavert Pharmaceuticals, a preclinical stage pharmaceutical company focused on precision medicine cancer therapies, announced today that it has obtained a full exclusive license on RAL GTPase (RAL) inhibitors from the University of Colorado. The licensed patent portfolio covers small molecule RAL inhibitors against KRAS muta

DALLAS and SAN DIEGO, Aug. 27, 2019 /PRNewswire/ -- AMN Healthcare, the leader and innovator in healthcare workforce solutions and staffing services, has named Christine Mackey-Ross as Lead Executive Partner of Phillips DiPisa, an AMN Healthcare company.

HOUSTON, Aug. 27, 2019 /PRNewswire/ -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal tissue ablation, announced today publication of first in human data of the company's AuroLase® Therapy for the focal ablation of prostate tissue.  Initial study outcomes we

PHILADELPHIA, Aug. 27, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a three-year advisory services agreement with its strategic alliance partner, Cediprof, Inc., a wholly owned subsidiary of privately held Neolpharma Group.  This agreement is separate and in addition to the supply and distribution agreemen

DENVER, Aug. 27, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 9 countries around the world, announced today that it will hold its Capital Markets Day in New York City on Tuesday, September 10, 2019

WASHINGTON, Aug. 27, 2019 /PRNewswire/ -- Mental Health for US today released survey responses from the top presidential candidates concerning our nation's growing mental health and addiction crises. The survey, which asked 11 unbiased questions addressing suicide and drug overdose, criminal justice reform, equal access to care, and more, aimed to get top candidat